Funding for this research was provided by:
Comprehensive Cancer Center, University of Alabama at Birmingham (Cancer center core grant(CA 13148))
Text and Data Mining valid from 2019-01-02
Received: 7 September 2018
Accepted: 29 November 2018
First Online: 2 January 2019
Compliance with ethical standards
: Dr. Francisco Robert: He is a member of speaker bureau for Boehringer Ingelheim. He is not involved with any of the drugs in this clinical study. No affiliations with or involvement in any organization or entity with any financial interest. All the authors declare that they have no potential conflicts of interest.